SOPHiA GENETICS SA (SOPH)
- Previous Close
4.6100 - Open
4.6500 - Bid 4.4700 x 100
- Ask 4.6400 x 100
- Day's Range
4.5000 - 4.7100 - 52 Week Range
2.1300 - 7.3700 - Volume
39,411 - Avg. Volume
75,111 - Market Cap (intraday)
296.803M - Beta (5Y Monthly) 1.17
- PE Ratio (TTM)
-- - EPS (TTM)
-1.2200 - Earnings Date Aug 6, 2024 - Aug 12, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
8.67
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.
www.sophiagenetics.com430
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SOPH
Performance Overview: SOPH
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SOPH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SOPH
Valuation Measures
Market Cap
296.80M
Enterprise Value
210.51M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.60
Price/Book (mrq)
2.24
Enterprise Value/Revenue
3.28
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-126.63%
Return on Assets (ttm)
-20.78%
Return on Equity (ttm)
-44.93%
Revenue (ttm)
62.37M
Net Income Avi to Common (ttm)
-78.98M
Diluted EPS (ttm)
-1.2200
Balance Sheet and Cash Flow
Total Cash (mrq)
123.25M
Total Debt/Equity (mrq)
12.28%
Levered Free Cash Flow (ttm)
-31.34M
Research Analysis: SOPH
Company Insights: SOPH
SOPH does not have Company Insights